We are live on ! Find out more
SC

Stance Capital Portfolio holdings

AUM $328M
1-Year Est. Return 48.17%
This Fund
S&P 500
This Quarter Est. Return
+31.52%
1 Year Est. Return
+48.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$328M
AUM Growth
+$122M
Cap. Flow
+$83.8M
Cap. Flow %
25.52%
Top 10 Hldgs %
22.4%
Holding
426
New
146
Increased
72
Reduced
74
Closed
86

Top Buys

Rank Stock Value
1
ROL icon
Rollins
ROL
+$4.54M
2
CMCSA icon
Comcast
CMCSA
+$3.72M
3
AMAT icon
Applied Materials
AMAT
+$3.67M
4
GILD icon
Gilead Sciences
GILD
+$3.5M
5
INTC icon
Intel
INTC
+$3.46M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.36M
2
WDC icon
Western Digital
WDC
+$3.74M
3
VTRS icon
Viatris
VTRS
+$3.61M
4
EBAY icon
eBay
EBAY
+$3.6M
5
HPQ icon
HP
HPQ
+$3.37M

Sector Composition

Rank Sector Weight
1 Technology 31.14%
2 Consumer Discretionary 12.31%
3 Healthcare 10.12%
4 Industrials 9.84%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
51
Arista Networks
ANET
$252B
$1.93M 0.59%
11,368
+1,372
+14% +$216K
ABBV icon
52
AbbVie
ABBV
$456B
$1.93M 0.59%
7,664
+1,517
+25% +$326K
ECL icon
53
Ecolab
ECL
$77.6B
$1.93M 0.59%
6,920
+1,959
+39% +$516K
NET icon
54
Cloudflare
NET
$108B
$1.92M 0.59%
7,837
+1,111
+17% +$243K
FTNT icon
55
Fortinet
FTNT
$114B
$1.91M 0.58%
12,424
-4,750
-28% -$549K
GFS icon
56
GlobalFoundries
GFS
$25.9B
$1.9M 0.58%
+23,070
New +$1.61M
MRK icon
57
Merck
MRK
$359B
$1.9M 0.58%
14,779
+2,460
+20% +$288K
PFE icon
58
Pfizer
PFE
$157B
$1.9M 0.58%
+78,762
New +$2.06M
SYF icon
59
Synchrony
SYF
$24.7B
$1.89M 0.58%
24,842
+24,642
+12,321% +$1.81M
NVDA icon
60
NVIDIA
NVDA
$5.29T
$1.89M 0.58%
9,439
+8,569
+985% +$1.76M
KEYS icon
61
Keysight
KEYS
$57.6B
$1.88M 0.57%
+5,380
New +$1.83M
NDSN icon
62
Nordson
NDSN
$17.5B
$1.87M 0.57%
+6,187
New +$1.76M
CARR icon
63
Carrier Global
CARR
$48B
$1.86M 0.57%
25,385
+418
+2% +$27.3K
TXN icon
64
Texas Instruments
TXN
$247B
$1.85M 0.56%
6,219
-11,813
-66% -$3.28M
SPG icon
65
Simon Property Group
SPG
$66.4B
$1.84M 0.56%
8,248
+7,908
+2,326% +$1.63M
EME icon
66
Emcor
EME
$34.5B
$1.84M 0.56%
2,218
+287
+15% +$243K
LLY icon
67
Eli Lilly
LLY
$999B
$1.84M 0.56%
1,530
+134
+10% +$137K
WRB icon
68
W.R. Berkley
WRB
$25.9B
$1.83M 0.56%
25,938
-23,277
-47% -$1.56M
KVUE icon
69
Kenvue
KVUE
$34.3B
$1.83M 0.56%
95,591
+17,899
+23% +$315K
V icon
70
Visa
V
$693B
$1.82M 0.56%
+5,313
New +$1.71M
MA icon
71
Mastercard
MA
$500B
$1.82M 0.55%
3,545
-4,944
-58% -$2.47M
CRWV
72
CoreWeave
CRWV
$49B
$1.82M 0.55%
+18,242
New +$1.97M
SCHW
73
Charles Schwab
SCHW
$185B
$1.81M 0.55%
19,656
+19,256
+4,814% +$1.76M
AZO icon
74
AutoZone
AZO
$47B
$1.81M 0.55%
566
-768
-58% -$2.55M
NTRS icon
75
Northern Trust
NTRS
$34.6B
$1.81M 0.55%
+10,393
New +$1.71M

Similar funds

Stance Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Stance Capital held 426 positions worth $328M, up 59% from $206M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Stance Capital deployed $83.8M of net new capital in Q2 2026, opening 146 new positions and adding to 72 existing holdings. Its largest new stake was Rollins: 88,929 shares worth $3.71M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $4.36M trimmed.

  • Stance Capital's largest Q2 2026 buy was Rollins: 88,929 shares worth $3.71M.
  • Stance Capital added most to Comcast in Q2 2026, an estimated $3.72M increase.
  • Stance Capital's biggest Q2 2026 reduction was Bristol-Myers Squibb, cutting an estimated $4.36M.
  • Stance Capital fully exited Bank of New York Mellon in Q2 2026, selling an estimated $1.43M.
  • Stance Capital's ten largest holdings make up 22% of its $328M portfolio in Q2 2026.
  • Stance Capital opened 146 new positions and closed 86 in Q2 2026.
  • Stance Capital's portfolio value rose 59% quarter-over-quarter to $328M.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.